Target intelligence / Profile preview

Detrusor function

Molecular classification
Other
01

Overview

Detrusor function refers to the physiological coordination of the detrusor urinae muscle, the smooth muscle component of the urinary bladder wall responsible for storing and expelling urine (StatPearls, "Physiology, Bladder"). It is not a singular molecular target but a physiological endpoint regulated by the autonomic nervous system via several receptors, most notably the muscarinic M3 and beta-3 adrenergic receptors (NIH, "Detrusor muscle activity"). During the filling phase, the detrusor remains relaxed to accommodate volume; during micturition, parasympathetic signals trigger contraction to void the bladder (PubMed). Clinical disorders such as overactive bladder (OAB) are characterized by detrusor overactivity, which leads to symptoms of urgency and frequency (Journal of Urology). Pharmacological management involves targeting specific receptors on the detrusor myocytes—such as using muscarinic antagonists like oxybutynin to reduce contractions or beta-3 agonists like mirabegron to enhance relaxation (Mayo Clinic). Consequently, while detrusor function is a critical parameter for evaluating drug efficacy in urology, it represents a complex biological process rather than a discrete therapeutic molecule.

Other names
Bladder contractionDetrusor muscle activityMicturitionVoiding function
02

Mechanism of action

Modulation of detrusor activity is achieved through the antagonism of muscarinic acetylcholine receptors (primarily M3) to inhibit involuntary contractions or the agonism of beta-3 adrenergic receptors to facilitate bladder relaxation and storage capacity.

03

Biological functions

Muscle contractionUrinationBladder storage
04

Disease associations

Overactive bladderUrinary incontinenceDetrusor underactivityNeurogenic bladderDetrusor-sphincter dyssynergia
05

Safety considerations

Urinary retentionAnticholinergic side effects (dry mouth, constipation, blurred vision)Cognitive impairment in elderly populationsIncreased blood pressure (associated with beta-3 agonists)
06

Interacting drugs

Oxybutynin

8 more in the full profile.

07

Biomarkers

Urodynamic pressure-flow studyCystometrogramMaximum urinary flow rate (Qmax)Post-void residual volume (PVR)

Beyond the preview

Go deeper on Detrusor function.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Detrusor function.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call